Tower Research Capital (TRC)’s Matinas BioPharma MTNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $981 | Sell |
1,102
-6
| -0.5% | -$5 | ﹤0.01% | 4894 |
|
|
2025
Q1 | $576 | Buy |
1,108
+6
| +0.5% | +$3 | ﹤0.01% | 4868 |
|
|
2024
Q4 | $562 | Buy |
+1,102
| New | +$562 | ﹤0.01% | 5236 |
|
|
2024
Q3 | – | Sell |
-931
| Closed | -$7.35K | – | 5892 |
|
|
2024
Q2 | $7.35K | Buy |
931
+347
| +59% | +$2.74K | ﹤0.01% | 4473 |
|
|
2024
Q1 | $7.91K | Sell |
584
-214
| -27% | -$2.9K | ﹤0.01% | 4114 |
|
|
2023
Q4 | $8.62K | Sell |
798
-136
| -15% | -$1.47K | ﹤0.01% | 4487 |
|
|
2023
Q3 | $6.07K | Buy |
934
+774
| +484% | +$5.03K | ﹤0.01% | 4646 |
|
|
2023
Q2 | $2.88K | Sell |
160
-265
| -62% | -$4.77K | ﹤0.01% | 5115 |
|
|
2023
Q1 | $10K | Buy |
425
+100
| +31% | +$2.35K | ﹤0.01% | 4377 |
|
|
2022
Q4 | $8K | Sell |
325
-62
| -16% | -$1.53K | ﹤0.01% | 4427 |
|
|
2022
Q3 | $12K | Buy |
+387
| New | +$12K | ﹤0.01% | 4356 |
|
|
2022
Q2 | – | Sell |
-112
| Closed | -$5K | – | 6362 |
|
|
2022
Q1 | $5K | Buy |
+112
| New | +$5K | ﹤0.01% | 5077 |
|
|
2021
Q4 | – | Sell |
-919
| Closed | -$60K | – | 6399 |
|
|
2021
Q3 | $60K | Buy |
+919
| New | +$60K | ﹤0.01% | 2810 |
|
|
2021
Q2 | – | Sell |
-1,580
| Closed | -$83K | – | 5705 |
|
|
2021
Q1 | $83K | Buy |
1,580
+1,432
| +968% | +$75.2K | ﹤0.01% | 2731 |
|
|
2020
Q4 | $10K | Buy |
148
+146
| +7,300% | +$9.87K | ﹤0.01% | 4316 |
|
|
2020
Q3 | $0 | Hold |
2
| – | – | ﹤0.01% | 4997 |
|
|
2020
Q2 | $0 | Hold |
2
| – | – | ﹤0.01% | 4891 |
|
|
2020
Q1 | $0 | Buy |
+2
| New | – | ﹤0.01% | 3581 |
|
|
2018
Q3 | – | Sell |
-111
| Closed | -$2K | – | 4073 |
|
|
2018
Q2 | $2K | Buy |
+111
| New | +$2K | ﹤0.01% | 3345 |
|
|
2018
Q1 | – | Sell |
-424
| Closed | -$25K | – | 3665 |
|
|
2017
Q4 | $25K | Buy |
+424
| New | +$25K | ﹤0.01% | 1885 |
|
|
2017
Q3 | – | Sell |
-265
| Closed | -$22K | – | 4081 |
|
|
2017
Q2 | $22K | Buy |
+265
| New | +$22K | ﹤0.01% | 1166 |
|